Loading...
Loading...
Contributors:
Dataset URI:
10.6084/m9.figshare.32567757.v1Tissue-resident memory T (TRM) cells play a role in causing long-term tissue injury in chronic inflammatory diseases via pathological epigenetic reprogramming. Nevertheless, the epigenetic processes that cause this malfunction have not been well defined. We performed integrative multi-omics analysis of TRM cells (CD3+CD8+CD69+CD103+, >92% purity, >94% viability) from 124 patients (41 rheumatoid arthritis, 43 inflammatory bowel disease, 40 psoriasis) and 35 healthy controls, employing scATAC-seq, ChIP-seq, whole-genome bisulfite sequencing, and scRNA-seq. We identified 847 differentially methylated regions (p80% in ex vivo assays. Machine learning classification achieved 94.2% accuracy (95% CI: 91.3–97.1%) distinguishing pathogenic from protective TRM cells. This first epigenetic atlas of TRM cells in chronic inflammation reveals tissue-specific vulnerabilities, therapeutic targets (DNMT1, EZH2), and patient stratification biomarkers. Limitations include the ex vivo validation system and the need for larger multicentric biomarker validation studies. Our body has special immune cells that stay inside tissues and help fight infection quickly. In long-lasting illnesses such as arthritis, bowel inflammation, and psoriasis, these cells can stop being helpful and start causing damage. This study examined these cells in samples from 124 patients and 35 healthy people. The study found changes in the chemical signals that control how genes are switched on and off. These changes were different in different body tissues, which may help explain why these illnesses affect different organs in different ways. The study also identified two possible drug targets that reduced harmful inflammatory signals in short laboratory tests. In addition, a small group of markers showed promise for predicting which patients may respond better to treatment. These findings may help support more targeted treatments in the future, although larger studies are still needed.
Keyword(s):
autoimmunity; Biological Sciences not elsewhere classified; Cancer; Cell Biology; Chemical Sciences not elsewhere classified.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)